Outlook on China's Pharma Development — 2004

Abstract

China's pharmaceutical industry is undergoing tremendous positive transformations, spurred both by the government's economic and political policies and the increasing investment/involvement by foreign pharma firms in China. This paper will describe the three major forces driving the changes: economic, regulatory and China's entrance into the World Trade Organization. These changes will contribute to China's emergence in the next decade as a major force in the international pharmaceutical arena, but the speed with which this will happen is contingent on overcoming the still-existing problems of intellectual property enforcement, regulatory capabilities, innovative skills and meeting EU/US good manufacturing practice quality and compliance requirements.